Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Poliorix™ Vaccine

NCT01021293 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1101

Enrollment

INDUSTRY

Sponsor class

Conditions

Poliomyelitis
Poliomyelitis Vaccines

Interventions

BIOLOGICAL: Poliorix™
BIOLOGICAL: Oral Poliovirus vaccine

Sponsor

GlaxoSmithKline